Dingdang Health Executes HK$0.34 Million Share Buyback, Treasury Stock Climbs to 3.94 Million Shares

Bulletin Express09-09

Dingdang Health Technology Group Ltd. disclosed a repurchase of 420,000 ordinary shares on 9 September 2026, executed on the Hong Kong Stock Exchange at prices ranging from HK$0.79 to HK$0.81 per share. The volume-weighted average purchase price was HK$0.8007, resulting in an aggregate consideration of HK$0.34 million.

Following the transaction, Dingdang Health’s outstanding share count (excluding treasury shares) declined by 0.03% to 1.24 billion, while the company’s treasury stock increased to 3.94 million shares. Total issued shares remained constant at 1.24 billion.

The buyback formed part of the mandate approved by shareholders on 23 June 2026, which authorises the company to repurchase up to 124.32 million shares. Cumulative repurchases under this mandate now stand at 6.80 million shares, equivalent to 0.55% of the issued share base on the mandate date.

Under Hong Kong listing rules, Dingdang Health is subject to a moratorium on new share issuance or sale of treasury shares until 9 October 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1119410576?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-09 19:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1119410576","market":"us","top_or_hot":-1,"title":"Dingdang Health Executes HK$0.34 Million Share Buyback, Treasury Stock Climbs to 3.94 Million Shares","media":"Bulletin Express","content":"<p>Dingdang Health Technology Group Ltd. disclosed a repurchase of 420,000 ordinary shares on 9 September 2026, executed on the Hong Kong Stock Exchange at prices ranging from HK$0.79 to HK$0.81 per share. The volume-weighted average purchase price was HK$0.8007, resulting in an aggregate consideration of HK$0.34 million.</p>\n<p>Following the transaction, Dingdang Health’s outstanding share count (excluding treasury shares) declined by 0.03% to 1.24 billion, while the company’s treasury stock increased to 3.94 million shares. Total issued shares remained constant at 1.24 billion.</p>\n<p>The buyback formed part of the mandate approved by shareholders on 23 June 2026, which authorises the company to repurchase up to 124.32 million shares. Cumulative repurchases under this mandate now stand at 6.80 million shares, equivalent to 0.55% of the issued share base on the mandate date.</p>\n<p>Under Hong Kong listing rules, Dingdang Health is subject to a moratorium on new share issuance or sale of treasury shares until 9 October 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dingdang Health Executes HK$0.34 Million Share Buyback, Treasury Stock Climbs to 3.94 Million Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDingdang Health Executes HK$0.34 Million Share Buyback, Treasury Stock Climbs to 3.94 Million Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-09-09 19:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dingdang Health Technology Group Ltd. disclosed a repurchase of 420,000 ordinary shares on 9 September 2026, executed on the Hong Kong Stock Exchange at prices ranging from HK$0.79 to HK$0.81 per share. The volume-weighted average purchase price was HK$0.8007, resulting in an aggregate consideration of HK$0.34 million.</p>\n<p>Following the transaction, Dingdang Health’s outstanding share count (excluding treasury shares) declined by 0.03% to 1.24 billion, while the company’s treasury stock increased to 3.94 million shares. Total issued shares remained constant at 1.24 billion.</p>\n<p>The buyback formed part of the mandate approved by shareholders on 23 June 2026, which authorises the company to repurchase up to 124.32 million shares. Cumulative repurchases under this mandate now stand at 6.80 million shares, equivalent to 0.55% of the issued share base on the mandate date.</p>\n<p>Under Hong Kong listing rules, Dingdang Health is subject to a moratorium on new share issuance or sale of treasury shares until 9 October 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09886","symbol_name":"叮当健康","start_time":0,"source_url":"","article_id":"1119410576","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1119410576","pubTimestamp":1788951835,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Dingdang Health Technology Group Ltd. disclosed a repurchase of 420,000 ordinary shares on 9 September 2026, executed on the Hong Kong Stock Exchange at prices ranging from HK$0.79 to HK$0.81 per...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09886":"叮当健康"},"translate_title":"叮当健康执行34万港元股票回购，库存股攀升至394万股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09886":1},"content_text":"Dingdang Health Technology Group Ltd. disclosed a repurchase of 420,000 ordinary shares on 9 September 2026, executed on the Hong Kong Stock Exchange at prices ranging from HK$0.79 to HK$0.81 per share. The volume-weighted average purchase price was HK$0.8007, resulting in an aggregate consideration of HK$0.34 million.\nFollowing the transaction, Dingdang Health’s outstanding share count (excluding treasury shares) declined by 0.03% to 1.24 billion, while the company’s treasury stock increased to 3.94 million shares. Total issued shares remained constant at 1.24 billion.\nThe buyback formed part of the mandate approved by shareholders on 23 June 2026, which authorises the company to repurchase up to 124.32 million shares. Cumulative repurchases under this mandate now stand at 6.80 million shares, equivalent to 0.55% of the issued share base on the mandate date.\nUnder Hong Kong listing rules, Dingdang Health is subject to a moratorium on new share issuance or sale of treasury shares until 9 October 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1119410576","isCrawlerRequest":true}